Resonance Health is pleased to announce the appointment of KNS in Canada who will launch a local presence for FerriScan at the forthcoming 2015 Pan-Canadian Thalassemia Conference taking place in Toronto on September 25-26th.
Canada is a strong market for FerriScan, especially in the haemoglobinopathy patient setting. KNS will now seek to address additional markets for the FerriScan technology in this country and aim to make FerriScan more widely available throughout all provinces for patients at risk from iron overload.
KNS Canada is a very successful distributor for non-invasive tests in the hepatology and gastroenterology clinical communities across the country, with a strong infrastructure of representatives and network of contacts.
Melanie Baxter, Marketing Director at Resonance Health said:
“A growing number of hospitals are accessing the FerriScan technology in Canada and we have successfully achieved inclusion in guidelines for care for haemoglobinopathy patients and coverage for FerriScan from the Ministry of Health in Ontario. The timing is now right to introduce a local presence and KNS is ideally positioned to expand on our activities in Canada, improve market access and address potential new markets.”
For further information regarding the Pan-Canadian Thalassemia Conference please click here.